Analyst Ratings For Pacira Pharmaceuticals (NASDAQ:PCRX)
Today, Pacira Pharmaceuticals (NASDAQ:PCRX) stock was downgraded by Canaccord Genuity from Hold to with a price target of $33.00.
There are 1 sell rating, 7 hold ratings, 9 buy ratings on the stock.
The current consensus rating on Pacira Pharmaceuticals (NASDAQ:PCRX) is Hold (Score: 2.47) with a consensus target price of $51.08 per share, a potential 53.85% upside.
Some recent analyst ratings include
- 10/30/2017-Canaccord Genuity was Downgraded by analysts at Canaccord Genuity from a “Hold” rating to a “” rating. They now have a $33.00 price target on the stock.
- 10/27/2017-Piper Jaffray Companies Reiterated Rating of Buy.
- 10/26/2017-Janney Montgomery Scott was Downgraded by analysts at Janney Montgomery Scott from a “Neutral ” rating to a ” Sell” rating. They now have a $27.00 price target on the stock.
- 10/25/2017-Wedbush Reiterated Rating of Outperform.
- 10/13/2017-Royal Bank Of Canada Reiterated Rating of Buy.
- On 8/22/2017 Paul J Hastings, Director, sold 1,044 with an average share price of $36.15 per share and the total transaction amounting to $37,740.60. View SEC Filing
- On 8/15/2017 David M Stack, CEO, sold 28,885 with an average share price of $36.37 per share and the total transaction amounting to $1,050,547.45. View SEC Filing
- On 8/15/2017 Kristen Marie Williams, CAO, sold 3,461 with an average share price of $36.75 per share and the total transaction amounting to $127,191.75. View SEC Filing
- On 8/8/2017 Mark Froimson, Director, bought 100 with an average share price of $37.13 per share and the total transaction amounting to $3,713.00. View SEC Filing
- On 6/5/2017 David M Stack, CEO, sold 4,311 with an average share price of $43.32 per share and the total transaction amounting to $186,752.52. View SEC Filing
- On 6/5/2017 James S Scibetta, President, sold 1,966 with an average share price of $43.32 per share and the total transaction amounting to $85,167.12. View SEC Filing
- On 6/5/2017 Kristen Marie Williams, CAO, sold 1,877 with an average share price of $43.32 per share and the total transaction amounting to $81,311.64. View SEC Filing
Recent Trading Activity for Pacira Pharmaceuticals (NASDAQ:PCRX)
Shares of Pacira Pharmaceuticals closed the previous trading session at with shares trading hands.